fenofibrate and acipimox

fenofibrate has been researched along with acipimox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chojnowska-Jezierska, J; Jabłoński, S; Tkaczewski, W1
Cutfield, WS; Gluckman, PD; Hofman, PL; Lobie, PE; Vickers, MH1

Other Studies

3 other study(ies) available for fenofibrate and acipimox

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Clinical effectiveness of acipimox and fenofibrate in patients with hyperlipoproteinemia type II].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1993, Volume: 46, Issue:9-10

    Topics: Adult; Aged; Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Treatment Outcome

1993
Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 291, Issue:6

    Topics: Animals; Birth Weight; Blood Pressure; Bone Development; Fatty Acids, Nonesterified; Female; Fenofibrate; Growth; Growth Hormone; Hematocrit; Hypolipidemic Agents; Insulin; Insulin-Like Growth Factor I; Liver; Male; Organ Size; Pregnancy; Pyrazines; Rats; Rats, Wistar; Tibia; Weight Gain

2006